Enanta Pharmaceuticals Inc. buy melinda
Start price
14.08.18
/
50%
€79.18
Target price
20.09.18
€106.44
Performance (%)
8.36%
End price
20.09.18
€85.80
Summary
This prediction ended on 20.09.18 with a price of €85.80. With a performance of 8.36%, the BUY prediction by melinda for Enanta Pharmaceuticals Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Enanta Pharmaceuticals Inc. | -3.252% | -3.252% | -29.586% | -68.519% |
iShares Core DAX® | 0.393% | -2.618% | 11.310% | 10.727% |
iShares Nasdaq 100 | 0.394% | -10.309% | 23.697% | 33.228% |
iShares Nikkei 225® | 1.038% | -8.365% | 7.878% | 1.931% |
iShares S&P 500 | -0.046% | -4.991% | 21.704% | 34.810% |
Comments by melinda for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 05/09 Présentation
Develops drugs and other pharmaceuticals products
Enanta Pharmaceuticals, Inc. engages in the research and development of small molecule drugs for the treatment of viral infections and liver diseases.
It offers the two protease inhibitors Maviret and the Viekira Pak for the treatment of chronic hepatitis C virus.
The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
Enanta Pharmaceuticals, Inc. engages in the research and development of small molecule drugs for the treatment of viral infections and liver diseases.
It offers the two protease inhibitors Maviret and the Viekira Pak for the treatment of chronic hepatitis C virus.
The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
Nombre d'employés : 89 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€47.80
15.02.20
15.02.20
€56.20
04.11.21
04.11.21
77.82%
05.11.21
05.11.21
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€80.37
06.02.18
06.02.18
€104.45
15.05.18
15.05.18
14.15%
15.05.18
15.05.18
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.52
23.10.17
23.10.17
€45.10
27.10.17
27.10.17
3.78%
27.10.17
27.10.17
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€48.25
23.10.17
23.10.17
€50.00
27.10.17
27.10.17
3.78%
27.10.17
27.10.17
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.12
20.10.17
20.10.17
€43.75
23.10.17
23.10.17
1.64%
23.10.17
23.10.17
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€47.81
20.10.17
20.10.17
€48.50
23.10.17
23.10.17
1.64%
23.10.17
23.10.17